Claimants are calling the bankruptcy settlement of Garlock Sealing Technologies unfair to victims of asbestos exposure. The challenge emerged out of the proposed amount that...
Read PostAustralian Man Celebrates Remission of Mesothelioma
Clinical Trials, Mesothelioma Research, News
By: Andrew Devine
June 19, 2015
Australian researchers have developed a treatment for mesothelioma that has already led to the almost no trace of one patient’s disease. The drug, known as TargomiRs, uses...
Read PostInsulators Team Up to Promote Mesothelioma Internship
Mesothelioma Research, News
By: Andrew Devine
June 15, 2015
The International Association of Heat and Frost Insulators and the Meso Foundation recently funded an internship for a Notre Dame student to conduct mesothelioma research. Alissa...
Read PostHope Surrounding New Treatment for Rare Form of Mesothelioma
Awareness, Clinical Trials, News
By: Andrew Devine
June 3, 2015
A new drug for rare cases of mesothelioma has just passed Phase II clinical trials in an Italian study. The drug showed a promising survival benefit in mesothelioma patients with...
Read PostTreatment for Inoperable Mesothelioma Greatly Improves Survival
Clinical Trials, News, Prognosis
By: Andrew Devine
May 23, 2015
On May 18, Dr. Lee Krug announced via Twitter that a phase III clinical trial found that a novel drug improves survival rates in mesothelioma patients. The drug bevacizumab proved...
Read PostDoctors Extol Novel Treatments at Mesothelioma Symposium
Doctors, Mesothelioma Research
By: Andrew Devine
May 8, 2015
The 5th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma was held in Santa Monica, CA on May 2, 2015. The audience included pulmonary...
Read PostAsbestos Bill Could Empower Current and Future Mesothelioma Patients
Advocacy, News
By: Andrew Devine
May 1, 2015
House representatives Suzan DelBene and Gene Green introduced legislation on Monday that would modernize current asbestos reporting laws. If it becomes law, the Reducing Exposure...
Read PostDr. Evan Alley Announces Results from Advanced Mesothelioma Study
Clinical Trials, News
By: Andrew Devine
April 23, 2015
On Monday, Dr. Evan Alley announced the results from a Phase 1b clinical trial for patients with advanced mesothelioma at the 2015 American Association for Cancer Research Annual...
Read PostDrug for Advanced Mesothelioma Is Gaining Momentum
Mesothelioma Research, News
By: Andrew Devine
April 17, 2015
Mesothelioma specialists have become increasingly optimistic about immunotherapy treatments, and the one that seems to be taking center stage is tremelimumab. Doctors recently...
Read PostHow National Asbestos Awareness Week Benefits Mesothelioma Patients
Advocacy, Awareness
By: Andrew Devine
April 1, 2015
Today kicks off the 11th annual National Asbestos Awareness Week, which coincides with Global Asbestos Awareness Week. The goals of this week are multifaceted, with an emphasis on...
Read Post